Search Results - "PACANA, Tommy"

Refine Results
  1. 1
  2. 2

    Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease by Pacana, Tommy, Cazanave, Sophie, Verdianelli, Aurora, Patel, Vaishali, Min, Hae-Ki, Mirshahi, Faridoddin, Quinlivan, Eoin, Sanyal, Arun J

    Published in PloS one (31-08-2015)
    “…Methionine metabolism plays a central role in methylation reactions, production of glutathione and methylarginines, and modulating homocysteine levels. The…”
    Get full text
    Journal Article
  3. 3

    A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori by PATRICK BASU, P, RAYAPUDI, Krishna, PACANA, Tommy, SHAH, Niraj James, KRISHNASWAMY, Nithya, FLYNN, Molly

    Published in The American journal of gastroenterology (01-11-2011)
    “…Resistance to standard Helicobacter pylori (HP) treatment regimens has led to unsatisfactory cure rates in HP-infected patients. This study was designed to…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Prevalence of restless legs syndrome in patients with irritable bowel syndrome by Basu, P Patrick, Shah, N James, Krishnaswamy, Nithya, Pacana, Tommy

    Published in World journal of gastroenterology : WJG (21-10-2011)
    “…AIM:To determine the prevalence of restless legs syn-drome(RLS)in patients with irritable bowel syndrome(IBS).METHODS:Patients with diarrhea-predominant…”
    Get full text
    Journal Article
  6. 6

    The Cardiovascular Link to Nonalcoholic Fatty Liver Disease by Pacana, Tommy, MD, Fuchs, Michael, MD, PhD, FEBG, AGAF

    Published in Clinics in liver disease (01-08-2012)
    “…Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western countries and can progress from simple steatosis to nonalcoholic…”
    Get full text
    Journal Article
  7. 7

    Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial by Basu, P. Patrick, Dinani, Amreen, Rayapudi, Krishna, Pacana, Tommy, Shah, Niraj James, Hampole, Hemant, Krishnaswamy, N.V., Mohan, Vinod

    Published in Therapeutic advances in gastroenterology (01-07-2010)
    “…Background: Clostridium difficile infection (CDI) is a recent epidemic in the United States, particularly in the hospital setting. Oral metronidazole is…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Vitamin E and nonalcoholic fatty liver disease by Pacana, Tommy, Sanyal, Arun J

    “…PURPOSE OF REVIEWOxidative stress plays a central role in the transition from simple steatosis to nonalcoholic steatohepatitis (NASH). An effective therapeutic…”
    Get full text
    Journal Article
  10. 10

    The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis by Pacana, Tommy, Fuchs, Michael

    Published in Clinics in liver disease (01-08-2012)
    “…Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western countries and can progress from simple steatosis to nonalcoholic…”
    Get full text
    Journal Article
  11. 11

    A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease by Sanyal, Arun J, Pacana, Tommy

    “…Multiple changes in lipid metabolism occur in nonalcoholic fatty liver disease. However, it is not known which of these contribute to disease progression. The…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Recent advances in understanding/management of non-alcoholic steatohepatitis by Pacana, Tommy, Sanyal, Arun J

    Published in F1000 prime reports (03-03-2015)
    “…Non-alcoholic steatohepatitis (NASH) can lead to advanced fibrosis, hepatocellular carcinoma, and end-stage liver disease requiring liver transplantation. A…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20